MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Return to MSDS List , First MSDS in list. , Last MSDS in list. M A T E R I A L S A F E T Y D A T A S H E E T Generated 07/21/2010, Revision 07/21/2010, Supercedes Revision 11/12/2009, Date Created 11/12/2009 SECTION 1. Product and Company Identification HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Product Code: HH-IVER Product Name:
HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Reference #: ANADA Manufacturer Information Company Name: Distributed Emergency Contact: Alternate Emergency Contact: Information: Preparer Name: S Additional Identity Information 100503595 6.08g (0.21 oz) box packaging 100503652 6.08g (0.21 oz) cello packaging SECTION 2. Composition/Information on Ingredients HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Hazardous Components (Chemical Name) Concentration
methylpropyl)-22,23-dihydro-25-(1-methylethyl)-
SECTION 3. Hazards Identification HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Emergency Overview KEEP OUT OF REACH OF CHILDREN Route(s) of Entry:
Inhalation? N.A. , Skin? Yes , Eyes? Yes , Ingestion? Yes
Potential Health Effects (Acute and Chronic) None known Signs and Symptoms Of Exposure None known
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Medical Conditions Generally Aggravated By Exposure None known SECTION 4. First Aid Measures HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Emergency and First Aid Procedures IF INGESTED: If accidental ingestion occurs, get medical attention immediately. IF IN EYES: Immediately flush eyes with plenty of water for 15 minutes. Seek medical attention if irritation persists. IF ON SKIN: Wash contact area with soap and water. Remove contaminated clothing and wash before reuse. If irritation occurs or persists, get medical attention. Note to Physician None SECTION 5. Fire Fighting Measures HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Flash Pt: NA Explosive Limits: Autoignition Pt: NA Fire Fighting Instructions Firefighters should wear self-contained breathing apparatus and full protective equipment. Flammable Properties and Hazards None known Hazardous Combustion Products None known Extinguishing Media Use water spray or all purpose dry chemical. Unsuitable Extinguishing Media None known SECTION 6. Accidental Release Measures HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Steps To Be Taken In Case Material Is Released Or Spilled Shovel spill into disposal containers. Rinse spill site with detergent and water. Use suitable protective gear. SECTION 7. Handling and Storage HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Precautions To Be Taken in Handling Do Not Smoke. Avoid contact with eyes, skin and clothing. Wash hands after use. Precautions To Be Taken in Storing Store in cool dry place away from heat and sunlight. Other Precautions
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Refrain from smoking and eating when handling. Wash hands after use. Avoid contact with eyes. SECTION 8. Exposure Controls/Personal Protection HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Respiratory Equipment (Specify Type) None Eye Protection Wear safety goggles Protective Gloves Wear rubber gloves Other Protective Clothing None needed except for manufacturing situations or large spills of product. Engineering Controls (Ventilation etc.) Local exhaust sufficient. Work/Hygienic/Maintenance Practices Wash hands before eating, smoking, or using restroom. SECTION 9. Physical and Chemical Properties HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Physical States: Melting Point: NA Boiling Point: NA Autoignition Pt: NA Flash Pt: NA Explosive Limits: Specific Gravity (Water = 1): Density: Bulk density: Vapor Pressure (vs. Air or mm NA Hg): Vapor Density (vs. Air = 1): Evaporation Rate (vs Butyl Acetate=1): Solubility in Water: No Solubility Notes Dispersible Percent Volatile: NA VOC / Volume: NA Heat Value: Particle Size: Corrosion Rate: Appearance and Odor Clear, colorless paste
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
SECTION 10. Stability and Reactivity HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Stability: Conditions To Avoid - Instability NE Incompatibility - Materials To Avoid None known Hazardous Decomposition Or Byproducts None known Hazardous Polymerization: Conditions To Avoid - Hazardous Polymerization None known SECTION 11. Toxicological Information HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
No data available Carcinogenicity/Other Information Ivermectin is not listed as a carcinogen with NTP, OSHA, or IARC. Hazardous Components (Chemical Name) NTP IARC ACGIH OSHA
Avermectin A1a, 5-O-demethyl-25-de(1-methylpropyl)-
Carcinogenicity:
NTP? No IARC Monographs? No OSHA Regulated? No
SECTION 12. Ecological Information HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
Ivermectin and excreted ivermectin residues may adversely affect aquatic organisms. Do not contaminate ground or surface water. Dispose of the syringe in an approved landfill or by incineration. SECTION 13. Disposal Considerations HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Waste Disposal Method Dispose of in accordance with local, state and federal regulations. SECTION 14. Transport Information HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% LAND TRANSPORT (US DOT) DOT Proper Shipping Name Not regulated as hazardous by U.S. DOT. DOT Hazard Label: None
MSDS: HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87%
SECTION 15. Regulatory Information HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% SECTION 16. Other Information HORSE HEALTH EQUINE IVERMECTIN PASTE 1.87% Company Policy or Disclaimer The information and data herein are believed to be accurate and have been compiled from sources believed to be reliable. It is offered for your consideration, investigation and verification.
Gesundheit Departement Gesundheit ZHAW Publikationsliste 2007 23. 05. 2008 Die fett markierten (Ko-) AutorInnen sind Mitarbeitende des Departements Gesundheit. 1. Publikationen referierten Zeitschriften (mit Peer Review) Brodbeck, J., Matter, M., Page, J. & Moggi, F. (2007). Motives for cannabis use as a moderator variable of distress among young adults.
Editorial Commentary Migrainous stroke Reports of migraine-associated stroke appear in the medical literature with regularity, but uncertainty persists as to themechanisms which may generate this uncommon complication of a common condition. In their article in this issue Drs Saninand Mathew describe a patient with migrainous stroke and arteriographic findings consistent with diffuse cerebral